PUBLISHER: TechNavio | PRODUCT CODE: 1581845
PUBLISHER: TechNavio | PRODUCT CODE: 1581845
Hypothyroidism Market 2024-2028
The hypothyroidism market is forecasted to grow by USD 789.8 million during 2023-2028, accelerating at a CAGR of 6.8% during the forecast period. The report on the hypothyroidism market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing approval of new hypothyroidism drugs, rise in thyroid treatment awareness programs, and increasing iodine-deficient population.
Market Scope | |
---|---|
Base Year | 2024 |
End Year | 2028 |
Series Year | 2024-2028 |
Growth Momentum | Accelerate |
YOY 2024 | 5.8% |
CAGR | 6.8% |
Incremental Value | $789.8 mn |
Technavio's hypothyroidism market is segmented as below:
By Disease Type
By Distribution Channel
By Geographical Landscape
This study identifies the inorganic growth strategies among market vendors as one of the prime reasons driving the hypothyroidism market growth during the next few years. Also, increasing clinical trials of hypothyroidism therapeutics and growing treatment options for hypothyroidism will lead to sizable demand in the market.
The report on the hypothyroidism market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hypothyroidism market vendors that include AbbVie Inc., AdvaCare Pharma, Alvogen Inc, Aurore Life Sciences Pvt Ltd, Biophore India Pharmaceuticals Pvt. Ltd., IBSA Institut Biochimique SA, JEROME STEVENS PHARMACEUTICALS INC., LLOYD Inc., Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., RLC Labs Inc., Sigmapharm Laboratories LLC, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Wockhardt Ltd., and Zydus Lifesciences Ltd.. Also, the hypothyroidism market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: